4-(Pyrrolidin-1-yl)butan-1-amine → 5-[1-(4-cyanophenyl)-1H-pyrazol-5-yl]-6-methyl-2-oxo-N-(4-pyrrolidin-1-ylbutyl)-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide
Reaction equation
[C:1]([C:3]1[CH:8]=[CH:7][C:6]([N:9]2[C:13]([C:14]3[CH:15]=[C:16]([C:32]([O:34]CC)=O)[C:17](=[O:31])[N:18]([C:21]4[CH:26]=[CH:25][CH:24]=[C:23]([C:27]([F:30])([F:29])[F:28])[CH:22]=4)[C:19]=3[CH3:20])=[CH:12][CH:11]=[N:10]2)=[CH:5][CH:4]=1)#[N:2].[N:37]1([CH2:42][CH2:43][CH2:44][CH2:45][NH2:46])[CH2:41][CH2:40][CH2:39][CH2:38]1>>[C:1]([C:3]1[CH:4]=[CH:5][C:6]([N:9]2[C:13]([C:14]3[CH:15]=[C:16]([C:32]([NH:46][CH2:45][CH2:44][CH2:43][CH2:42][N:37]4[CH2:41][CH2:40][CH2:39][CH2:38]4)=[O:34])[C:17](=[O:31])[N:18]([C:21]4[CH:26]=[CH:25][CH:24]=[C:23]([C:27]([F:30])([F:29])[F:28])[CH:22]=4)[C:19]=3[CH3:20])=[CH:12][CH:11]=[N:10]2)=[CH:7][CH:8]=1)#[N:2]Participants
3
Reactant 2
Product 1
Procedure
Intermediate A and 4-pyrrolidin-1-ylbutan-1-amine were reacted together using an analogous method to that described in Step 1 of Example 1 to afford 5-[1-(4-cyanophenyl)-1H-pyrazol-5-yl]-6-methyl-2-oxo-N-(4-pyrrolidin-1-ylbutyl)-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide as a white solid (169 mg, 67%); 1H NMR (500 MHz, DMSO) δ 1.50-1.36 (4H, m), 1.63 (4H, dd), 1.73 (3H, s), 2.40-2.30 (6H, m), 3.24 (2H, q), 6.72 (1H, d), 7.65 (2H, d), 7.71 (1H, d), 7.87-7.81 (2H, m), 7.95-7.89 (4H, m), 8.06 (1H, s), 9.30 (1H, t); APCI-MSm/z: 589[MH+]
Sources & evidence
- ORD record
- ord-005ab67b956e4e6ba0f7be01361ba149
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08436024B2
Reaction notes
Loading…